LifeVantage (NASDAQ:LFVN) Posts Earnings Results

LifeVantage (NASDAQ:LFVN) issued its quarterly earnings data on Tuesday. The company reported $0.15 EPS for the quarter, hitting analysts’ consensus estimates of $0.15, Zacks reports. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%. The business had revenue of $47.21 million during the quarter. LifeVantage updated its FY 2025 guidance to 0.700-0.800 EPS.

LifeVantage Trading Down 1.2 %

Shares of LFVN stock traded down $0.16 during trading hours on Thursday, reaching $12.77. 11,045 shares of the stock were exchanged, compared to its average volume of 60,067. LifeVantage has a 12-month low of $4.20 and a 12-month high of $14.71. The company’s 50-day moving average price is $10.86 and its 200-day moving average price is $8.35. The firm has a market capitalization of $162.19 million, a price-to-earnings ratio of 46.18 and a beta of 0.84.

LifeVantage Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.25%. LifeVantage’s dividend payout ratio is presently 57.14%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.